SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹67 Cr |
Mar2023 | ₹108 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹46 Cr |
Mar2020 | ₹20 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹67 Cr | -38.00 | |
Mar2023 | ₹108 Cr | 15.99 | |
Mar2022 | ₹94 Cr | 103.03 | |
Mar2021 | ₹46 Cr | 135.46 | |
Mar2020 | ₹20 Cr | - |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹638.2 Cr | -2.2% | -8.4% | -26.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | -2.2% |
-8.4% |
-26.9% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses